연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1091. Treatment With mANT2 shRNA Enhances Antitumor Therapeutic Effects Induced by MUC1 DNA Vaccination.
Choi Y, Jeon YH, Jang JY, Chung JK, Kim CW.
Mol Ther. 2010 Nov 9.
Link
1090. Antitumor effects of combined granulocyte macrophage colony stimulating factor and macrophage inflammatory protein-3 alpha plasmid DNA.
Choi Y, Kim CW.
Cancer Sci. 2010 Nov;101(11):2341-50.
Link
1089. Feasibility of less radical surgery for superficially invasive carcinoma of the cervix.
Kim MK, Kim JW, Kim MA, Kim HS, Chung HH, Park NH, Park IA, Song YS, Kang SB.
Gynecol Oncol. 2010 Nov;119(2):187-91.
Link
1088. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
Koh Y, Kim I, Bae JY, Song EY, Kim HK, Yoon SS, Lee DS, Park SS, Park MH, Park S, Kim BK.
Jpn J Clin Oncol. 2010 Nov;40(11):1037-45.
Link
1087. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
Kang HJ, Shin HY, Park JE, Chung NG, Cho B, Kim HK, Kim SY, Lee YH, Lim YT, Yoo KH, Sung KW, Koo HH, Im HJ, Seo JJ, Park SK, Ahn HS; Korean Society of Pediatric Hematology-Oncology.
Biol Blood Marrow Transplant. 2010 Nov;16(11):1582-8.
Link
1086. Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer.
Li L, Lee KM, Han W, Choi JY, Lee JY, Kang GH, Park SK, Noh DY, Yoo KY, Kang D.
Hum Mol Genet. 2010 Nov 1;19(21):4273-7.
Link
1085. Formation and characterization of gallium complexes with monoamide derivatives of 1,4,7-triazacyclononane.
Jeong Jae Min.
Eur J inorg Chem.2010.5432-5438
Link
1084. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.
Cho YJ, Yoon J, Ko YS, Kim SY, Cho SJ, Kim WH, Park JW, Youn HD, Kim JH, Lee BL.
APMIS. 2010 Oct;118(10):782-90.
Link
1083. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
Koh Y, Lee HR, Song EY, Kim HK, Kim I, Park S, Park MH, Kim BK, Yoon SS, Lee DS.
Leuk Res. 2010 Oct;34(10):1344-50.
Link
1082. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
Koh Y, Lee HR, Song EY, Kim HK, Kim I, Park S, Park MH, Kim BK, Yoon SS, Lee DS.
Leuk Res. 2010 Oct;34(10):1344-50.
Link